BioeconomyAMsilk scaling up through Evonik collaborationFermatation expert Evonik SE has entered into an agreement with the German recombinant silk producer AMSilk to produce industrial quantities of innovative, sustainable silk proteins. more ➔
partnershipHOOKIPA bags US$10m cancer milestone HOOKIPA has received a US$10m milestone under its 2022 agreement with Roche to develop an arenaviral immunotherapy for KRAS-mutated cancers. more ➔
Cydar Medical Ltd raises €10.5m in Series A financingCambridge-based endovascular surgical AI specialist Cydar Medical has completed a €10.5m (£9.3m) Series A funding round led by Pembroke Venture Capital Trust more ➔
Upping sustainability in pharma packagingHow to make pharma packaging sustainable was one of the major discussion topics at PHARMAPACK 2023. more ➔
financingEvonetix extends Series B financing to US$54mBritish Evonetix Ltd has added US$$24m to its existing US$30m Series B financing round. The new financing was led by existing investor Foresite Capital. more ➔
financingGermany’s Curevac offers common sharesmRNA vaccine pioneer CureVac N.V. has announced that it will sell US$200m of its common shares in an underwritten public offering. more ➔
partnershipsChong Kun Dang Pharm licences Synaffix ADC platformSouth Korean Chong Kun Dang Pharm has licenced access to Amsterdam-based Synaffix BV’s propietary ADC platform. more ➔
Clinical trialsNew EU stakeholder platform to speed up clinical trialsA new platform is set to facilitate the exchange of information on the optimisation of the electronic reporting system CTIS. more ➔
Novel Food Ultra-processed foods increase risk for cancerBritish researchers have linked higher consumption of ultra-processed foods to an increased risk of developing and dying from cancer. more ➔
partnershipLonza collaborates with Asher Biotherapeutics IncAsher Biotherapeutics Inc has expanded its manufacturing agreement with Lonza to include the manufacturing of AB248. more ➔
